tiprankstipranks
Invizyne Technologies Inc. (IZTC)
NASDAQ:IZTC
US Market
Holding IZTC?
Track your performance easily

Invizyne Technologies Inc. (IZTC) Stock Price & Analysis

8 Followers

IZTC Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

56.27%43.73%
56.27% Insiders
― Other Institutional Investors
43.73% Public Companies and
Individual Investors

IZTC FAQ

What was Invizyne Technologies Inc.’s price range in the past 12 months?
Invizyne Technologies Inc. lowest stock price was $8.50 and its highest was $23.00 in the past 12 months.
    What is Invizyne Technologies Inc.’s market cap?
    Currently, no data Available
    When is Invizyne Technologies Inc.’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Invizyne Technologies Inc.’s earnings last quarter?
    Currently, no data Available
    Is Invizyne Technologies Inc. overvalued?
    According to Wall Street analysts Invizyne Technologies Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Invizyne Technologies Inc. pay dividends?
      Invizyne Technologies Inc. does not currently pay dividends.
      What is Invizyne Technologies Inc.’s EPS estimate?
      Invizyne Technologies Inc.’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Invizyne Technologies Inc. have?
      Invizyne Technologies Inc. has 8,127,349 shares outstanding.
        What happened to Invizyne Technologies Inc.’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Invizyne Technologies Inc.?
        Currently, no hedge funds are holding shares in IZTC
        ---

        Company Description

        Invizyne Technologies Inc.

        Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals. Our objective with SimplePath¿, our biomanufacturing platform, is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. We believe that SimplePath¿ not only can maximize the value of these resources but also will contribute to the development of novel chemical compounds that should open new markets and business opportunities.
        ---
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis